Abbott completes Topera deal for $250M

Candace Stuart | January 05, 2015 | Cardiovascular Business | Heart Rhythm

Abbott wrapped up 2014 by completing its acquisition of Topera, a company that develops electrophysiology technologies to diagnose and treat patients with atrial fibrillation.

Abbott acquired all outstanding equity of Topera in late December for $250 million, and agreed to potential future payments based on performance milestones. Topera develops diagnostic catheter and mapping software to help electrophysiologists identify and target patient-specific rotors suspected in atrial fibrillation. The mapping procedure is used to facilitate catheter ablation therapy.

Abbott is based in Abbott Park, Ill., and Topera is in Menlo Park, Calif. The acquisition completes a deal that was initiated in October 2014.

Candace Stuart, Contributor

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Abbott completes Topera deal for $250M

Related Content

Around the web